BioSpace Movers & Shakers, Jan. 1
The Pharma Data
DECEMBER 31, 2020
where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. Reimer replaces Charlotte Russel and will be responsible for Alligator’s drug development candidates, with an emphasis on bringing mitazalimab and ATOR-1017 into Phase II efficacy studies.
Let's personalize your content